nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—ABCB1—melanoma	0.158	1	CbGaD
Clonidine—SLC22A5—Dactinomycin—melanoma	0.121	0.211	CbGbCtD
Clonidine—CYP1A1—Dacarbazine—melanoma	0.0907	0.158	CbGbCtD
Clonidine—CYP1A2—Carmustine—melanoma	0.0669	0.116	CbGbCtD
Clonidine—CYP1A2—Vemurafenib—melanoma	0.0529	0.0921	CbGbCtD
Clonidine—CYP3A4—Temozolomide—melanoma	0.0505	0.088	CbGbCtD
Clonidine—CYP2D6—Vemurafenib—melanoma	0.0436	0.0759	CbGbCtD
Clonidine—CYP1A2—Dacarbazine—melanoma	0.0405	0.0706	CbGbCtD
Clonidine—ABCB1—Dactinomycin—melanoma	0.0307	0.0535	CbGbCtD
Clonidine—CYP3A4—Vemurafenib—melanoma	0.0277	0.0482	CbGbCtD
Clonidine—CYP3A5—Docetaxel—melanoma	0.0244	0.0424	CbGbCtD
Clonidine—ABCB1—Docetaxel—melanoma	0.0159	0.0276	CbGbCtD
Clonidine—CYP3A4—Docetaxel—melanoma	0.0095	0.0166	CbGbCtD
Clonidine—NISCH—Paclitaxel—Docetaxel—melanoma	0.00504	1	CbGdCrCtD
Clonidine—Diclofenac—CXCR1—melanoma	0.0038	0.688	CrCbGaD
Clonidine—Diclofenac—CXCL8—melanoma	0.00096	0.174	CrCbGaD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000655	0.00525	CcSEcCtD
Clonidine—Infection—Vemurafenib—melanoma	0.000628	0.00503	CcSEcCtD
Clonidine—Liver function test abnormal—Carmustine—melanoma	0.000628	0.00503	CcSEcCtD
Clonidine—Nervous system disorder—Vemurafenib—melanoma	0.00062	0.00497	CcSEcCtD
Clonidine—Skin disorder—Vemurafenib—melanoma	0.000614	0.00492	CcSEcCtD
Clonidine—Respiratory failure—Docetaxel—melanoma	0.000614	0.00491	CcSEcCtD
Clonidine—Breast disorder—Temozolomide—melanoma	0.000594	0.00476	CcSEcCtD
Clonidine—Hypotension—Vemurafenib—melanoma	0.000591	0.00473	CcSEcCtD
Clonidine—Influenza like illness—Docetaxel—melanoma	0.000585	0.00469	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000576	0.00462	CcSEcCtD
Clonidine—Decreased appetite—Vemurafenib—melanoma	0.00055	0.0044	CcSEcCtD
Clonidine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000546	0.00437	CcSEcCtD
Clonidine—Fatigue—Vemurafenib—melanoma	0.000545	0.00437	CcSEcCtD
Clonidine—Constipation—Vemurafenib—melanoma	0.000541	0.00433	CcSEcCtD
Clonidine—Hypoaesthesia—Bleomycin—melanoma	0.000537	0.0043	CcSEcCtD
Clonidine—Dysuria—Temozolomide—melanoma	0.000532	0.00426	CcSEcCtD
Clonidine—Upper respiratory tract infection—Temozolomide—melanoma	0.000528	0.00423	CcSEcCtD
Clonidine—Pollakiuria—Temozolomide—melanoma	0.000525	0.00421	CcSEcCtD
Clonidine—Erectile dysfunction—Temozolomide—melanoma	0.000524	0.00419	CcSEcCtD
Clonidine—Depression—Carmustine—melanoma	0.000523	0.00419	CcSEcCtD
Clonidine—Weight increased—Temozolomide—melanoma	0.000517	0.00414	CcSEcCtD
Clonidine—Urinary tract infection—Carmustine—melanoma	0.00051	0.00408	CcSEcCtD
Clonidine—Depression—Temozolomide—melanoma	0.000505	0.00405	CcSEcCtD
Clonidine—Hepatitis—Dactinomycin—melanoma	0.000503	0.00403	CcSEcCtD
Clonidine—Body temperature increased—Vemurafenib—melanoma	0.0005	0.00401	CcSEcCtD
Clonidine—Urinary tract infection—Temozolomide—melanoma	0.000493	0.00395	CcSEcCtD
Clonidine—Cardiac failure congestive—Docetaxel—melanoma	0.000482	0.00386	CcSEcCtD
Clonidine—Alopecia—Bleomycin—melanoma	0.000477	0.00382	CcSEcCtD
Clonidine—Erythema—Bleomycin—melanoma	0.00047	0.00376	CcSEcCtD
Clonidine—Hallucination—Carmustine—melanoma	0.000469	0.00375	CcSEcCtD
Clonidine—Hypoaesthesia—Carmustine—melanoma	0.000469	0.00375	CcSEcCtD
Clonidine—Hypersensitivity—Vemurafenib—melanoma	0.000466	0.00373	CcSEcCtD
Clonidine—Hepatitis—Temozolomide—melanoma	0.000455	0.00364	CcSEcCtD
Clonidine—Asthenia—Vemurafenib—melanoma	0.000454	0.00363	CcSEcCtD
Clonidine—Hypoaesthesia—Temozolomide—melanoma	0.000453	0.00363	CcSEcCtD
Clonidine—Hallucination—Temozolomide—melanoma	0.000453	0.00363	CcSEcCtD
Clonidine—Pruritus—Vemurafenib—melanoma	0.000448	0.00358	CcSEcCtD
Clonidine—Lethargy—Docetaxel—melanoma	0.000446	0.00358	CcSEcCtD
Clonidine—Alopecia—Dactinomycin—melanoma	0.000445	0.00356	CcSEcCtD
Clonidine—Eye disorder—Carmustine—melanoma	0.00044	0.00352	CcSEcCtD
Clonidine—Erythema—Dactinomycin—melanoma	0.000438	0.00351	CcSEcCtD
Clonidine—Pain in extremity—Docetaxel—melanoma	0.000437	0.0035	CcSEcCtD
Clonidine—Ill-defined disorder—Bleomycin—melanoma	0.000436	0.00349	CcSEcCtD
Clonidine—Diarrhoea—Vemurafenib—melanoma	0.000433	0.00347	CcSEcCtD
Clonidine—Eye disorder—Temozolomide—melanoma	0.000425	0.00341	CcSEcCtD
Clonidine—Tinnitus—Temozolomide—melanoma	0.000424	0.0034	CcSEcCtD
Clonidine—Malaise—Bleomycin—melanoma	0.000423	0.00339	CcSEcCtD
Clonidine—Cardiac disorder—Temozolomide—melanoma	0.000422	0.00338	CcSEcCtD
Clonidine—Arrhythmia—Carmustine—melanoma	0.000421	0.00337	CcSEcCtD
Clonidine—Dizziness—Vemurafenib—melanoma	0.000418	0.00335	CcSEcCtD
Clonidine—Alopecia—Carmustine—melanoma	0.000416	0.00333	CcSEcCtD
Clonidine—Angiopathy—Temozolomide—melanoma	0.000413	0.00331	CcSEcCtD
Clonidine—Mental disorder—Carmustine—melanoma	0.000413	0.0033	CcSEcCtD
Clonidine—Mediastinal disorder—Temozolomide—melanoma	0.00041	0.00328	CcSEcCtD
Clonidine—Erythema—Carmustine—melanoma	0.00041	0.00328	CcSEcCtD
Clonidine—Cough—Bleomycin—melanoma	0.00041	0.00328	CcSEcCtD
Clonidine—Ill-defined disorder—Dactinomycin—melanoma	0.000406	0.00325	CcSEcCtD
Clonidine—Liver function test abnormal—Docetaxel—melanoma	0.000404	0.00323	CcSEcCtD
Clonidine—Vomiting—Vemurafenib—melanoma	0.000402	0.00322	CcSEcCtD
Clonidine—Alopecia—Temozolomide—melanoma	0.000402	0.00322	CcSEcCtD
Clonidine—Chest pain—Bleomycin—melanoma	0.0004	0.0032	CcSEcCtD
Clonidine—Orthostatic hypotension—Docetaxel—melanoma	0.0004	0.0032	CcSEcCtD
Clonidine—Abdominal pain upper—Docetaxel—melanoma	0.0004	0.0032	CcSEcCtD
Clonidine—Rash—Vemurafenib—melanoma	0.000399	0.00319	CcSEcCtD
Clonidine—Mental disorder—Temozolomide—melanoma	0.000399	0.00319	CcSEcCtD
Clonidine—Dermatitis—Vemurafenib—melanoma	0.000398	0.00319	CcSEcCtD
Clonidine—Headache—Vemurafenib—melanoma	0.000396	0.00317	CcSEcCtD
Clonidine—Erythema—Temozolomide—melanoma	0.000396	0.00317	CcSEcCtD
Clonidine—Breast disorder—Docetaxel—melanoma	0.000395	0.00317	CcSEcCtD
Clonidine—Discomfort—Bleomycin—melanoma	0.000395	0.00316	CcSEcCtD
Clonidine—Malaise—Dactinomycin—melanoma	0.000395	0.00316	CcSEcCtD
Clonidine—Cramp muscle—Docetaxel—melanoma	0.000394	0.00315	CcSEcCtD
Clonidine—Nasopharyngitis—Docetaxel—melanoma	0.000391	0.00313	CcSEcCtD
Clonidine—Confusional state—Bleomycin—melanoma	0.000386	0.0031	CcSEcCtD
Clonidine—Vision blurred—Carmustine—melanoma	0.000386	0.00309	CcSEcCtD
Clonidine—Tremor—Carmustine—melanoma	0.000384	0.00308	CcSEcCtD
Clonidine—Oedema—Bleomycin—melanoma	0.000383	0.00307	CcSEcCtD
Clonidine—Infection—Bleomycin—melanoma	0.000381	0.00305	CcSEcCtD
Clonidine—Agitation—Carmustine—melanoma	0.000377	0.00302	CcSEcCtD
Clonidine—Nausea—Vemurafenib—melanoma	0.000376	0.00301	CcSEcCtD
Clonidine—Thrombocytopenia—Bleomycin—melanoma	0.000375	0.00301	CcSEcCtD
Clonidine—Vision blurred—Temozolomide—melanoma	0.000373	0.00299	CcSEcCtD
Clonidine—Tremor—Temozolomide—melanoma	0.000371	0.00297	CcSEcCtD
Clonidine—Discomfort—Dactinomycin—melanoma	0.000368	0.00295	CcSEcCtD
Clonidine—Ill-defined disorder—Temozolomide—melanoma	0.000368	0.00294	CcSEcCtD
Clonidine—Anorexia—Bleomycin—melanoma	0.000365	0.00293	CcSEcCtD
Clonidine—Agitation—Temozolomide—melanoma	0.000364	0.00292	CcSEcCtD
Clonidine—Angioedema—Temozolomide—melanoma	0.000362	0.0029	CcSEcCtD
Clonidine—Hypotension—Bleomycin—melanoma	0.000358	0.00287	CcSEcCtD
Clonidine—Oedema—Dactinomycin—melanoma	0.000357	0.00286	CcSEcCtD
Clonidine—Malaise—Temozolomide—melanoma	0.000357	0.00286	CcSEcCtD
Clonidine—Infection—Dactinomycin—melanoma	0.000355	0.00284	CcSEcCtD
Clonidine—Palpitations—Temozolomide—melanoma	0.00035	0.0028	CcSEcCtD
Clonidine—Thrombocytopenia—Dactinomycin—melanoma	0.00035	0.0028	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000349	0.0028	CcSEcCtD
Clonidine—Chest pain—Carmustine—melanoma	0.000349	0.00279	CcSEcCtD
Clonidine—Anxiety—Carmustine—melanoma	0.000348	0.00279	CcSEcCtD
Clonidine—Cough—Temozolomide—melanoma	0.000346	0.00277	CcSEcCtD
Clonidine—Paraesthesia—Bleomycin—melanoma	0.000344	0.00276	CcSEcCtD
Clonidine—Weight increased—Docetaxel—melanoma	0.000344	0.00276	CcSEcCtD
Clonidine—Dyspnoea—Bleomycin—melanoma	0.000342	0.00274	CcSEcCtD
Clonidine—Anorexia—Dactinomycin—melanoma	0.000341	0.00273	CcSEcCtD
Clonidine—Confusional state—Carmustine—melanoma	0.000337	0.0027	CcSEcCtD
Clonidine—Arthralgia—Temozolomide—melanoma	0.000337	0.0027	CcSEcCtD
Clonidine—Anxiety—Temozolomide—melanoma	0.000336	0.00269	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000335	0.00268	CcSEcCtD
Clonidine—Oedema—Carmustine—melanoma	0.000335	0.00268	CcSEcCtD
Clonidine—Discomfort—Temozolomide—melanoma	0.000333	0.00267	CcSEcCtD
Clonidine—Decreased appetite—Bleomycin—melanoma	0.000333	0.00267	CcSEcCtD
Clonidine—Infection—Carmustine—melanoma	0.000332	0.00266	CcSEcCtD
Clonidine—Dry mouth—Temozolomide—melanoma	0.00033	0.00264	CcSEcCtD
Clonidine—Pain—Bleomycin—melanoma	0.000328	0.00262	CcSEcCtD
Clonidine—Thrombocytopenia—Carmustine—melanoma	0.000328	0.00262	CcSEcCtD
Clonidine—Tachycardia—Carmustine—melanoma	0.000327	0.00261	CcSEcCtD
Clonidine—Confusional state—Temozolomide—melanoma	0.000326	0.00261	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000326	0.00261	CcSEcCtD
Clonidine—Oedema—Temozolomide—melanoma	0.000323	0.00259	CcSEcCtD
Clonidine—Infection—Temozolomide—melanoma	0.000321	0.00257	CcSEcCtD
Clonidine—Anorexia—Carmustine—melanoma	0.000319	0.00255	CcSEcCtD
Clonidine—Epistaxis—Docetaxel—melanoma	0.000318	0.00255	CcSEcCtD
Clonidine—Nervous system disorder—Temozolomide—melanoma	0.000317	0.00254	CcSEcCtD
Clonidine—Thrombocytopenia—Temozolomide—melanoma	0.000317	0.00254	CcSEcCtD
Clonidine—Feeling abnormal—Bleomycin—melanoma	0.000316	0.00253	CcSEcCtD
Clonidine—Skin disorder—Temozolomide—melanoma	0.000314	0.00252	CcSEcCtD
Clonidine—Hypotension—Carmustine—melanoma	0.000313	0.0025	CcSEcCtD
Clonidine—Hyperhidrosis—Temozolomide—melanoma	0.000313	0.0025	CcSEcCtD
Clonidine—Decreased appetite—Dactinomycin—melanoma	0.000311	0.00249	CcSEcCtD
Clonidine—Fatigue—Dactinomycin—melanoma	0.000308	0.00247	CcSEcCtD
Clonidine—Anorexia—Temozolomide—melanoma	0.000308	0.00247	CcSEcCtD
Clonidine—Pain—Dactinomycin—melanoma	0.000306	0.00245	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000305	0.00244	CcSEcCtD
Clonidine—Urticaria—Bleomycin—melanoma	0.000304	0.00244	CcSEcCtD
Clonidine—Rhinitis—Docetaxel—melanoma	0.000303	0.00243	CcSEcCtD
Clonidine—Body temperature increased—Bleomycin—melanoma	0.000303	0.00243	CcSEcCtD
Clonidine—Hepatitis—Docetaxel—melanoma	0.000303	0.00242	CcSEcCtD
Clonidine—Insomnia—Carmustine—melanoma	0.000303	0.00242	CcSEcCtD
Clonidine—Hypoaesthesia—Docetaxel—melanoma	0.000301	0.00241	CcSEcCtD
Clonidine—Paraesthesia—Carmustine—melanoma	0.0003	0.00241	CcSEcCtD
Clonidine—Dyspnoea—Carmustine—melanoma	0.000298	0.00239	CcSEcCtD
Clonidine—Somnolence—Carmustine—melanoma	0.000297	0.00238	CcSEcCtD
Clonidine—Feeling abnormal—Dactinomycin—melanoma	0.000295	0.00236	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000295	0.00236	CcSEcCtD
Clonidine—Insomnia—Temozolomide—melanoma	0.000292	0.00234	CcSEcCtD
Clonidine—Gastrointestinal pain—Dactinomycin—melanoma	0.000292	0.00234	CcSEcCtD
Clonidine—Decreased appetite—Carmustine—melanoma	0.000291	0.00233	CcSEcCtD
Clonidine—Paraesthesia—Temozolomide—melanoma	0.00029	0.00233	CcSEcCtD
Clonidine—Gastrointestinal disorder—Carmustine—melanoma	0.000289	0.00231	CcSEcCtD
Clonidine—Dyspnoea—Temozolomide—melanoma	0.000288	0.00231	CcSEcCtD
Clonidine—Somnolence—Temozolomide—melanoma	0.000287	0.0023	CcSEcCtD
Clonidine—Pain—Carmustine—melanoma	0.000286	0.00229	CcSEcCtD
Clonidine—Constipation—Carmustine—melanoma	0.000286	0.00229	CcSEcCtD
Clonidine—Eye disorder—Docetaxel—melanoma	0.000283	0.00226	CcSEcCtD
Clonidine—Abdominal pain—Dactinomycin—melanoma	0.000283	0.00226	CcSEcCtD
Clonidine—Body temperature increased—Dactinomycin—melanoma	0.000283	0.00226	CcSEcCtD
Clonidine—Hypersensitivity—Bleomycin—melanoma	0.000282	0.00226	CcSEcCtD
Clonidine—Decreased appetite—Temozolomide—melanoma	0.000281	0.00225	CcSEcCtD
Clonidine—Cardiac disorder—Docetaxel—melanoma	0.000281	0.00225	CcSEcCtD
Clonidine—Diclofenac—PTGS2—melanoma	0.00028	0.0506	CrCbGaD
Clonidine—Gastrointestinal disorder—Temozolomide—melanoma	0.000279	0.00224	CcSEcCtD
Clonidine—Fatigue—Temozolomide—melanoma	0.000279	0.00223	CcSEcCtD
Clonidine—Constipation—Temozolomide—melanoma	0.000276	0.00221	CcSEcCtD
Clonidine—Pain—Temozolomide—melanoma	0.000276	0.00221	CcSEcCtD
Clonidine—Feeling abnormal—Carmustine—melanoma	0.000276	0.00221	CcSEcCtD
Clonidine—Asthenia—Bleomycin—melanoma	0.000275	0.0022	CcSEcCtD
Clonidine—Angiopathy—Docetaxel—melanoma	0.000275	0.0022	CcSEcCtD
Clonidine—Gastrointestinal pain—Carmustine—melanoma	0.000274	0.00219	CcSEcCtD
Clonidine—Mediastinal disorder—Docetaxel—melanoma	0.000273	0.00218	CcSEcCtD
Clonidine—Pruritus—Bleomycin—melanoma	0.000271	0.00217	CcSEcCtD
Clonidine—Arrhythmia—Docetaxel—melanoma	0.00027	0.00217	CcSEcCtD
Clonidine—Alopecia—Docetaxel—melanoma	0.000267	0.00214	CcSEcCtD
Clonidine—Feeling abnormal—Temozolomide—melanoma	0.000266	0.00213	CcSEcCtD
Clonidine—Mental disorder—Docetaxel—melanoma	0.000265	0.00212	CcSEcCtD
Clonidine—Body temperature increased—Carmustine—melanoma	0.000264	0.00212	CcSEcCtD
Clonidine—Abdominal pain—Carmustine—melanoma	0.000264	0.00212	CcSEcCtD
Clonidine—Gastrointestinal pain—Temozolomide—melanoma	0.000264	0.00212	CcSEcCtD
Clonidine—Erythema—Docetaxel—melanoma	0.000263	0.00211	CcSEcCtD
Clonidine—Hypersensitivity—Dactinomycin—melanoma	0.000263	0.00211	CcSEcCtD
Clonidine—Urticaria—Temozolomide—melanoma	0.000257	0.00206	CcSEcCtD
Clonidine—Asthenia—Dactinomycin—melanoma	0.000256	0.00205	CcSEcCtD
Clonidine—Abdominal pain—Temozolomide—melanoma	0.000256	0.00205	CcSEcCtD
Clonidine—Body temperature increased—Temozolomide—melanoma	0.000256	0.00205	CcSEcCtD
Clonidine—Muscle spasms—Docetaxel—melanoma	0.000253	0.00203	CcSEcCtD
Clonidine—Diclofenac—ALB—melanoma	0.000249	0.0451	CrCbGaD
Clonidine—Hypersensitivity—Carmustine—melanoma	0.000246	0.00197	CcSEcCtD
Clonidine—Diarrhoea—Dactinomycin—melanoma	0.000245	0.00196	CcSEcCtD
Clonidine—Vomiting—Bleomycin—melanoma	0.000244	0.00195	CcSEcCtD
Clonidine—Rash—Bleomycin—melanoma	0.000242	0.00194	CcSEcCtD
Clonidine—Dermatitis—Bleomycin—melanoma	0.000241	0.00193	CcSEcCtD
Clonidine—Asthenia—Carmustine—melanoma	0.00024	0.00192	CcSEcCtD
Clonidine—Hypersensitivity—Temozolomide—melanoma	0.000238	0.00191	CcSEcCtD
Clonidine—Diclofenac—ABCB1—melanoma	0.000238	0.043	CrCbGaD
Clonidine—Syncope—Docetaxel—melanoma	0.000236	0.00189	CcSEcCtD
Clonidine—Palpitations—Docetaxel—melanoma	0.000233	0.00186	CcSEcCtD
Clonidine—Asthenia—Temozolomide—melanoma	0.000232	0.00186	CcSEcCtD
Clonidine—Loss of consciousness—Docetaxel—melanoma	0.000232	0.00185	CcSEcCtD
Clonidine—Cough—Docetaxel—melanoma	0.00023	0.00184	CcSEcCtD
Clonidine—Diarrhoea—Carmustine—melanoma	0.000229	0.00183	CcSEcCtD
Clonidine—Pruritus—Temozolomide—melanoma	0.000229	0.00183	CcSEcCtD
Clonidine—Nausea—Bleomycin—melanoma	0.000228	0.00182	CcSEcCtD
Clonidine—Vomiting—Dactinomycin—melanoma	0.000227	0.00182	CcSEcCtD
Clonidine—Rash—Dactinomycin—melanoma	0.000225	0.0018	CcSEcCtD
Clonidine—Arthralgia—Docetaxel—melanoma	0.000224	0.0018	CcSEcCtD
Clonidine—Chest pain—Docetaxel—melanoma	0.000224	0.0018	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000223	0.00178	CcSEcCtD
Clonidine—Dizziness—Carmustine—melanoma	0.000221	0.00177	CcSEcCtD
Clonidine—Diarrhoea—Temozolomide—melanoma	0.000221	0.00177	CcSEcCtD
Clonidine—Dry mouth—Docetaxel—melanoma	0.000219	0.00176	CcSEcCtD
Clonidine—Confusional state—Docetaxel—melanoma	0.000217	0.00174	CcSEcCtD
Clonidine—Oedema—Docetaxel—melanoma	0.000215	0.00172	CcSEcCtD
Clonidine—Dizziness—Temozolomide—melanoma	0.000214	0.00171	CcSEcCtD
Clonidine—Infection—Docetaxel—melanoma	0.000214	0.00171	CcSEcCtD
Clonidine—Vomiting—Carmustine—melanoma	0.000213	0.0017	CcSEcCtD
Clonidine—Nausea—Dactinomycin—melanoma	0.000212	0.0017	CcSEcCtD
Clonidine—Shock—Docetaxel—melanoma	0.000212	0.00169	CcSEcCtD
Clonidine—Rash—Carmustine—melanoma	0.000211	0.00169	CcSEcCtD
Clonidine—Nervous system disorder—Docetaxel—melanoma	0.000211	0.00169	CcSEcCtD
Clonidine—Dermatitis—Carmustine—melanoma	0.000211	0.00169	CcSEcCtD
Clonidine—Thrombocytopenia—Docetaxel—melanoma	0.00021	0.00169	CcSEcCtD
Clonidine—Tachycardia—Docetaxel—melanoma	0.00021	0.00168	CcSEcCtD
Clonidine—Headache—Carmustine—melanoma	0.00021	0.00168	CcSEcCtD
Clonidine—Skin disorder—Docetaxel—melanoma	0.000209	0.00167	CcSEcCtD
Clonidine—Vomiting—Temozolomide—melanoma	0.000206	0.00165	CcSEcCtD
Clonidine—Anorexia—Docetaxel—melanoma	0.000205	0.00164	CcSEcCtD
Clonidine—Rash—Temozolomide—melanoma	0.000204	0.00163	CcSEcCtD
Clonidine—Dermatitis—Temozolomide—melanoma	0.000204	0.00163	CcSEcCtD
Clonidine—Headache—Temozolomide—melanoma	0.000203	0.00162	CcSEcCtD
Clonidine—Hypotension—Docetaxel—melanoma	0.000201	0.00161	CcSEcCtD
Clonidine—Nausea—Carmustine—melanoma	0.000199	0.00159	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000196	0.00157	CcSEcCtD
Clonidine—Insomnia—Docetaxel—melanoma	0.000194	0.00156	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—melanoma	0.000193	0.00155	CcSEcCtD
Clonidine—Nausea—Temozolomide—melanoma	0.000192	0.00154	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—melanoma	0.000192	0.00154	CcSEcCtD
Clonidine—Somnolence—Docetaxel—melanoma	0.000191	0.00153	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—melanoma	0.000187	0.0015	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—melanoma	0.000186	0.00149	CcSEcCtD
Clonidine—Fatigue—Docetaxel—melanoma	0.000185	0.00148	CcSEcCtD
Clonidine—Pain—Docetaxel—melanoma	0.000184	0.00147	CcSEcCtD
Clonidine—Constipation—Docetaxel—melanoma	0.000184	0.00147	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—melanoma	0.000177	0.00142	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—melanoma	0.000176	0.00141	CcSEcCtD
Clonidine—Body temperature increased—Docetaxel—melanoma	0.00017	0.00136	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—melanoma	0.00017	0.00136	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—melanoma	0.000158	0.00127	CcSEcCtD
Clonidine—Asthenia—Docetaxel—melanoma	0.000154	0.00124	CcSEcCtD
Clonidine—Pruritus—Docetaxel—melanoma	0.000152	0.00122	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—melanoma	0.000147	0.00118	CcSEcCtD
Clonidine—Dizziness—Docetaxel—melanoma	0.000142	0.00114	CcSEcCtD
Clonidine—Vomiting—Docetaxel—melanoma	0.000137	0.00109	CcSEcCtD
Clonidine—Rash—Docetaxel—melanoma	0.000136	0.00109	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—melanoma	0.000135	0.00108	CcSEcCtD
Clonidine—Headache—Docetaxel—melanoma	0.000135	0.00108	CcSEcCtD
Clonidine—Nausea—Docetaxel—melanoma	0.000128	0.00102	CcSEcCtD
Clonidine—CYP3A4—Metabolism—GNA11—melanoma	5.26e-06	3.98e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NFKB1—melanoma	5.26e-06	3.98e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	5.24e-06	3.96e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK3—melanoma	5.23e-06	3.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—melanoma	5.23e-06	3.95e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MDM2—melanoma	5.22e-06	3.95e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAP2K1—melanoma	5.21e-06	3.94e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ALB—melanoma	5.2e-06	3.93e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1B—melanoma	5.18e-06	3.92e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CD—melanoma	5.17e-06	3.91e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CB—melanoma	5.16e-06	3.9e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—melanoma	5.15e-06	3.9e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—FASN—melanoma	5.15e-06	3.9e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—melanoma	5.14e-06	3.89e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—BRAF—melanoma	5.14e-06	3.89e-05	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—melanoma	5.12e-06	3.88e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	5.12e-06	3.88e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—melanoma	5.11e-06	3.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—melanoma	5.08e-06	3.84e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CB—melanoma	5.07e-06	3.84e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—melanoma	5.07e-06	3.84e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC5A5—melanoma	5.07e-06	3.83e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—melanoma	5.06e-06	3.83e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—melanoma	5.04e-06	3.82e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—melanoma	5.03e-06	3.81e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CB—melanoma	5.01e-06	3.79e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCB1—melanoma	5.01e-06	3.79e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1—melanoma	5e-06	3.79e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK1—melanoma	4.98e-06	3.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—melanoma	4.98e-06	3.77e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CD—melanoma	4.98e-06	3.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—melanoma	4.96e-06	3.76e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—melanoma	4.96e-06	3.75e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGF2—melanoma	4.95e-06	3.75e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—melanoma	4.94e-06	3.74e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—melanoma	4.92e-06	3.73e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—melanoma	4.91e-06	3.72e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—melanoma	4.89e-06	3.7e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CD44—melanoma	4.89e-06	3.7e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNAQ—melanoma	4.89e-06	3.7e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—melanoma	4.88e-06	3.69e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—melanoma	4.85e-06	3.67e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1B—melanoma	4.84e-06	3.66e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	4.84e-06	3.66e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	4.81e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—melanoma	4.8e-06	3.63e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—melanoma	4.79e-06	3.62e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1A—melanoma	4.78e-06	3.62e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—melanoma	4.77e-06	3.61e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—melanoma	4.77e-06	3.61e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1B—melanoma	4.76e-06	3.6e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	4.76e-06	3.6e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NFKB1—melanoma	4.75e-06	3.59e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—melanoma	4.74e-06	3.59e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—melanoma	4.74e-06	3.58e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—melanoma	4.73e-06	3.58e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—melanoma	4.71e-06	3.57e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—melanoma	4.71e-06	3.57e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—melanoma	4.71e-06	3.57e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—melanoma	4.7e-06	3.56e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1B1—melanoma	4.69e-06	3.55e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—melanoma	4.67e-06	3.53e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—melanoma	4.66e-06	3.53e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—melanoma	4.65e-06	3.52e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	4.65e-06	3.52e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—melanoma	4.64e-06	3.51e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MDM2—melanoma	4.63e-06	3.51e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—melanoma	4.62e-06	3.49e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PRKCA—melanoma	4.61e-06	3.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGF2—melanoma	4.6e-06	3.48e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—melanoma	4.59e-06	3.47e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—melanoma	4.57e-06	3.46e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ERCC2—melanoma	4.57e-06	3.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—melanoma	4.57e-06	3.46e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—melanoma	4.55e-06	3.44e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—melanoma	4.54e-06	3.44e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—melanoma	4.52e-06	3.42e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—melanoma	4.51e-06	3.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—melanoma	4.51e-06	3.41e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—melanoma	4.5e-06	3.4e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—melanoma	4.48e-06	3.39e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1A—melanoma	4.47e-06	3.38e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—melanoma	4.46e-06	3.37e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NFKB1—melanoma	4.43e-06	3.36e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—melanoma	4.41e-06	3.34e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	4.4e-06	3.33e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—melanoma	4.39e-06	3.32e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—melanoma	4.39e-06	3.32e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NFKB1—melanoma	4.36e-06	3.3e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—melanoma	4.36e-06	3.3e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—melanoma	4.35e-06	3.29e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—melanoma	4.34e-06	3.28e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—melanoma	4.33e-06	3.28e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—melanoma	4.33e-06	3.28e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	4.32e-06	3.27e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—melanoma	4.31e-06	3.26e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MDM2—melanoma	4.3e-06	3.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—melanoma	4.3e-06	3.26e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—melanoma	4.3e-06	3.25e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK1—melanoma	4.3e-06	3.25e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—melanoma	4.29e-06	3.25e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—melanoma	4.28e-06	3.24e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—melanoma	4.27e-06	3.23e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—melanoma	4.26e-06	3.22e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—melanoma	4.26e-06	3.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—melanoma	4.24e-06	3.21e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	4.23e-06	3.2e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	4.19e-06	3.17e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	4.18e-06	3.17e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—melanoma	4.15e-06	3.14e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—melanoma	4.14e-06	3.13e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—melanoma	4.12e-06	3.12e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—melanoma	4.11e-06	3.11e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—melanoma	4.08e-06	3.08e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—melanoma	4.06e-06	3.07e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—melanoma	4.04e-06	3.05e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—melanoma	4.02e-06	3.05e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—melanoma	4.02e-06	3.05e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—melanoma	4e-06	3.03e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	4e-06	3.02e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—melanoma	3.99e-06	3.02e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—melanoma	3.98e-06	3.01e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—melanoma	3.97e-06	3.01e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—melanoma	3.97e-06	3e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—melanoma	3.96e-06	3e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—melanoma	3.96e-06	3e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	3.93e-06	2.97e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—melanoma	3.92e-06	2.97e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—melanoma	3.92e-06	2.97e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—melanoma	3.92e-06	2.97e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—melanoma	3.91e-06	2.96e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	3.9e-06	2.95e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—melanoma	3.9e-06	2.95e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	3.89e-06	2.94e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK1—melanoma	3.88e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—melanoma	3.88e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NFKB1—melanoma	3.88e-06	2.93e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—melanoma	3.86e-06	2.92e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—melanoma	3.85e-06	2.92e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—melanoma	3.85e-06	2.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—melanoma	3.83e-06	2.9e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—melanoma	3.81e-06	2.88e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—melanoma	3.8e-06	2.88e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.78e-06	2.86e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—melanoma	3.76e-06	2.84e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—melanoma	3.75e-06	2.84e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—melanoma	3.75e-06	2.84e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—melanoma	3.75e-06	2.84e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—melanoma	3.74e-06	2.83e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	3.73e-06	2.82e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.71e-06	2.81e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—melanoma	3.7e-06	2.8e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—melanoma	3.7e-06	2.8e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—melanoma	3.66e-06	2.77e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—melanoma	3.64e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—melanoma	3.64e-06	2.75e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	3.63e-06	2.75e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK1—melanoma	3.62e-06	2.74e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—melanoma	3.62e-06	2.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—melanoma	3.62e-06	2.74e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—melanoma	3.61e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—melanoma	3.61e-06	2.73e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—melanoma	3.6e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NFKB1—melanoma	3.6e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK1—melanoma	3.57e-06	2.7e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—melanoma	3.56e-06	2.7e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PRKCA—melanoma	3.56e-06	2.69e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—melanoma	3.53e-06	2.67e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ERCC2—melanoma	3.53e-06	2.67e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—melanoma	3.52e-06	2.66e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—melanoma	3.48e-06	2.64e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—melanoma	3.48e-06	2.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—melanoma	3.48e-06	2.63e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—melanoma	3.46e-06	2.62e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—melanoma	3.45e-06	2.61e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—melanoma	3.43e-06	2.6e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—melanoma	3.42e-06	2.59e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—melanoma	3.37e-06	2.55e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	3.37e-06	2.55e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—melanoma	3.33e-06	2.52e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—melanoma	3.3e-06	2.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—melanoma	3.27e-06	2.47e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—melanoma	3.26e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—melanoma	3.26e-06	2.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—melanoma	3.24e-06	2.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—melanoma	3.24e-06	2.45e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—melanoma	3.23e-06	2.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—melanoma	3.23e-06	2.44e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—melanoma	3.17e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK1—melanoma	3.17e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—melanoma	3.17e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—melanoma	3.14e-06	2.38e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—melanoma	3.13e-06	2.37e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—melanoma	3.11e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	3.09e-06	2.34e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—melanoma	3.09e-06	2.34e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—melanoma	3.07e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—melanoma	3.05e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—melanoma	3.05e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—melanoma	3.04e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—melanoma	3.01e-06	2.28e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—melanoma	2.99e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—melanoma	2.99e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—melanoma	2.99e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—melanoma	2.98e-06	2.26e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—melanoma	2.94e-06	2.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.94e-06	2.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—melanoma	2.94e-06	2.23e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—melanoma	2.91e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—melanoma	2.86e-06	2.17e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—melanoma	2.82e-06	2.13e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—melanoma	2.8e-06	2.12e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—melanoma	2.79e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—melanoma	2.78e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—melanoma	2.78e-06	2.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—melanoma	2.77e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—melanoma	2.75e-06	2.08e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.75e-06	2.08e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—melanoma	2.74e-06	2.07e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—melanoma	2.74e-06	2.07e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—melanoma	2.69e-06	2.03e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—melanoma	2.66e-06	2.01e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—melanoma	2.64e-06	2e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—melanoma	2.57e-06	1.94e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.55e-06	1.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—melanoma	2.54e-06	1.92e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—melanoma	2.53e-06	1.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—melanoma	2.49e-06	1.89e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—melanoma	2.47e-06	1.87e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—melanoma	2.45e-06	1.85e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—melanoma	2.43e-06	1.84e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—melanoma	2.42e-06	1.83e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—melanoma	2.39e-06	1.81e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.36e-06	1.79e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—melanoma	2.29e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—melanoma	2.26e-06	1.71e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—melanoma	2.24e-06	1.7e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—melanoma	2.16e-06	1.63e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—melanoma	2.13e-06	1.61e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—melanoma	2.11e-06	1.6e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—melanoma	2.11e-06	1.6e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—melanoma	2.09e-06	1.58e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—melanoma	1.99e-06	1.51e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—melanoma	1.84e-06	1.4e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—melanoma	1.72e-06	1.31e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—melanoma	1.69e-06	1.28e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—melanoma	1.63e-06	1.23e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—melanoma	1.38e-06	1.04e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—melanoma	1.3e-06	9.84e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—melanoma	1.06e-06	8.04e-06	CbGpPWpGaD
